Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,175 INR | +1.01% |
|
+1.09% | +70.51% |
Jul. 11 | Zydus Lifesciences Gets US FDA's Tentative Approval for Generic Multiple Sclerosis Drug | MT |
Jul. 11 | Zydus Lifesciences Gets US FDA's Final Nod for Sacubitril, Valsartan Tablets | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.51% | 14.16B | |
+25.24% | 45.32B | |
+34.85% | 24.51B | |
+29.56% | 16.85B | |
+21.32% | 14.62B | |
-0.05% | 6.79B | |
+15.74% | 5.82B | |
-8.87% | 5.73B | |
+10.29% | 4.93B | |
+30.91% | 4.84B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Zydus Lifesciences Gets US FDA Final Approval for Chemotherapy Medication